Notice of Intent to Award to Sole Source - EZ1&2 DNA Tissue Kit, Buffer AL, and Qiagen Proteinase K

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Qiagen LLC for Ez1 and 2 DNA Tissue Kits, Buffer AL, and Qiagen Protentianse K. Competition is being limited because Qiagen LLC. is the sole manufacturer of the products. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within seven days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist Sherrie Constantine at [email protected] by 10:00 AM EST 1 February 2023. Please see attached sole source justification for more information